Cytostatic agents in treatment of the nephrotic syndrome
Halvorsen, S.
Tidsskrift for den Norske Laegeforening Tidsskrift for Praktisk Medicin Ny Raekke 91(10): 737
1971
ISSN/ISBN: 0029-2001 PMID: 5577392 Document Number: 38292
Document emailed within 1 workday
Related Documents
Filimonova, R.G. 1976: Metabolism of peripheral blood lymphocytes in nephrotic syndrome and cytostatic therapy Terapevticheskii Arkhiv 48(5): 108-113Lumholtz, I.B. 1977: Drug information: agents in the treatment of neoplastic diseases. Therapeutic main group: cytostatic agents. 1 Sygeplejersken 77(16): 13
Steineck, G.; Wijkström, H.; Borghede, G. 1994: Treatment of bladder cancer with cytostatic agents Lakartidningen 91(5): 397-404
Chlund, K. 1970: Treatment of ulcerative colitis with cytostatic agents Wiener Medizinische Wochenschrift 120(16): 274
Rauh, J.; Pluntke, S.; Müller, C. 2004: Treatment of perivascular extravasation of cytostatic agents MMW Fortschritte der Medizin 146(31-32): 23-24; 26-27
Wisløff, F.; Brinch, L.; Bruserud, O.; Dahl, I.M.; Lamvik, J. 1994: Treatment with high-dose cytostatic agents Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 114(26): 3115-3116
Resić, H. 2002: Remission of nephrotic syndrome in patients treated with corticosteroids and other immunosuppressive agents Medicinski Arhiv 56(2): 85-88
Kshirsagar, N.A.; Shah, B.P.; Paul, T.; Acharya, V.N.; Sattur, P.B.; Sheth, U.K. 1979: Effect of nonsteroidal anti-inflammatory agents and diuretics in nephrotic syndrome patients Indian Journal of Medical Research 70: 801-806
Ringborg, U. 1990: Identification of resistance factors is a step towards optimized treatment with cytostatic agents Lakartidningen 87(21): 1880-1882
Larsson, P.A. 1999: Treatment with cytostatic agents should be considered in colorectal cancer. it improves prognosis and quality of life Lakartidningen 96(19): 2314-2316
Nilsson, A.; Björk, O. 2001: A mannose-binding blood protein reduces the risk of infections drug treatment with cytostatic agents Lakartidningen 98(50): 5780
Wyszyńska, T. 1975: Refractoriness to therapy in nephrotic syndrome in children. Part II. Clinico-morphological correlations in corticosteroid-resistant nephrotic syndrome in children Pediatria Polska 50(1): 9-18
Temes-Montes, X.L.; Picaporte, M.A.; Herrero, E.; Selgas, R.; Beberide, J.M.; Martínez-Ara, J.; Sánchez-Sicilia, L. 1980: Serum and urine zinc values in nephropathies expressed as nephrotic syndrome or nephrotic-range proteinuria Revista Clinica Espanola 159(3): 159-161
Lin, C.-Y.; Chien, J.-W. 2004: Increased interleukin-12 release from peripheral blood mononuclear cells in nephrotic phase of minimal change nephrotic syndrome Acta Paediatrica Taiwanica 45(2): 77-80
Furková, K.; Kaiserová, E.; Páleníková, O.; Hruskovic, I.; Slugen, I.; Arpasová, D.; Janota, S.; Nyulassy, S. 1990: Treatment of nephrotic syndrome with cyclosporin a Ceskoslovenska Pediatrie 45(10): 591-595
Guignard, J.P. 1978: Treatment of nephrotic syndrome in children Revue Medicale de la Suisse Romande 98(11): 593-598
Janda, J. 1983: The nephrotic syndrome in children and its treatment Ceskoslovenska Pediatrie 38(12): 732-736
McLigeyo, S.O. 1993: Symptomatic treatment of nephrotic syndrome East African Medical Journal 70(1): 1-2
Meyrier, A. 1997: Treatment of idiopathic nephrotic syndrome with cyclosporine a Journal of Nephrology 10(1): 14-24
Pandeva, S.M.; Tzekov, V.D.; Kumchev, E.P.; Tilkian, E.E.; Nikolov, D.G.; Tzvetkova, Z.T.; Manev, E.I.; Anavi, B.L.; Dimitrakov, D.J. 2000: Cyclosporin a in the treatment of patients with nephrotic syndrome Folia Medica 42(2): 38-41